Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 2
2009 3
2010 1
2012 1
2013 4
2014 1
2015 4
2016 5
2017 2
2018 1
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all The following term was ignored: )
Page 1
The Statin Choice decision aid in primary care: a randomized trial.
Mann DM, Ponieman D, Montori VM, Arciniega J, McGinn T. Mann DM, et al. Among authors: montori vm. Patient Educ Couns. 2010 Jul;80(1):138-40. doi: 10.1016/j.pec.2009.10.008. Epub 2009 Dec 2. Patient Educ Couns. 2010. PMID: 19959322 Clinical Trial.
RESULTS: Intervention patients were more likely to accurately perceive their underlying risk for a heart attack without taking a statin (OR: 1.9, CI: 1.0-3.8) and with taking a statin (OR: 1.4, CI: 0.7-2.8); a decline in risk overestimation among patients receiving …
RESULTS: Intervention patients were more likely to accurately perceive their underlying risk for a heart attack without taking a statin
Developing a toolkit to implement the Statin Choice Conversation Aid at scale: application of a work reduction model.
Leppin AL, Boehmer KR, Branda ME, Shah ND, Hargraves I, Dick S, Elwyn G, Ting HH, Ye S, Gilles R, Abbas M, Alexander A, Montori VM. Leppin AL, et al. Among authors: montori vm. BMC Health Serv Res. 2019 Apr 24;19(1):249. doi: 10.1186/s12913-019-4055-8. BMC Health Serv Res. 2019. PMID: 31018840 Free PMC article.
BACKGROUND: Guidelines recommend shared decision making (SDM) for determining whether to use statins to prevent cardiovascular events in at-risk patients. We sought to develop a toolkit to facilitate the cross-organizational spread and scale of a SDM intervention called th …
BACKGROUND: Guidelines recommend shared decision making (SDM) for determining whether to use statins to prevent cardiovascular events …
Shared decision-making following disclosure of coronary heart disease genetic risk: results from a randomized clinical trial.
Jouni H, Haddad RA, Marroush TS, Brown SA, Kruisselbrink TM, Austin EE, Shameer K, Behnken EM, Chaudhry R, Montori VM, Kullo IJ. Jouni H, et al. Among authors: montori vm. J Investig Med. 2017 Mar;65(3):681-688. doi: 10.1136/jim-2016-000318. Epub 2016 Dec 19. J Investig Med. 2017. PMID: 27993947 Free PMC article. Clinical Trial.
Whether disclosure of genetic risk for coronary heart disease (CHD) influences shared decision-making (SDM) regarding use of statins to reduce CHD risk is unknown. We randomized 207 patients, age 45-65 years, at intermediate CHD risk, and not on statins, to receive …
Whether disclosure of genetic risk for coronary heart disease (CHD) influences shared decision-making (SDM) regarding use of statins
Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial.
Weymiller AJ, Montori VM, Jones LA, Gafni A, Guyatt GH, Bryant SC, Christianson TJ, Mullan RJ, Smith SA. Weymiller AJ, et al. Among authors: montori vm. Arch Intern Med. 2007 May 28;167(10):1076-82. doi: 10.1001/archinte.167.10.1076. Arch Intern Med. 2007. PMID: 17533211 Clinical Trial.
Twenty-one endocrinologists conducted specialty outpatient metabolic consultations. Patients in the intervention group received Statin Choice, a tailored decision aid that presents the estimated 10-year cardiovascular risk, the absolute risk reduction with use of statin
Twenty-one endocrinologists conducted specialty outpatient metabolic consultations. Patients in the intervention group received Statin
An Informatics Approach to Implement Support for Shared Decision Making for Primary Prevention Statin Therapy.
Ye S, Leppin AL, Chan AY, Chang N, Moise N, Poghosyan L, Montori VM, Kronish I. Ye S, et al. Among authors: montori vm. MDM Policy Pract. 2018 May 22;3(1):2381468318777752. doi: 10.1177/2381468318777752. eCollection 2018 Jan-Jun. MDM Policy Pract. 2018. PMID: 30288449 Free PMC article.
Shared decision making (SDM) is recommended prior to initiation of statin therapy for primary prevention but is underutilized. We designed an informatics decision-support tool to facilitate use of the Mayo Clinic Statin Choice decision aid at the point-of-care and e …
Shared decision making (SDM) is recommended prior to initiation of statin therapy for primary prevention but is underutilized. We des …
Assessing the feasibility and quality of shared decision making in China: evaluating a clinical encounter intervention for Chinese patients.
Huang R, Song X, Wu J, Huang W, Leppin AL, Gionfriddo MR, Liu Y, Boehmer KR, Ting HH, Montori VM. Huang R, et al. Among authors: montori vm. Patient Prefer Adherence. 2016 Nov 14;10:2341-2350. doi: 10.2147/PPA.S115115. eCollection 2016. Patient Prefer Adherence. 2016. PMID: 27881912 Free PMC article.
BACKGROUND: The aim of this study was to evaluate the feasibility of using the Statin Choice decision aid to have discussions about starting a statin medication for cardiovascular risk reduction in Chinese patients with stable coronary artery diseases. ...After SDM, …
BACKGROUND: The aim of this study was to evaluate the feasibility of using the Statin Choice decision aid to have discussions about s …
Preferences and attitudes of young Chinese clinicians about using a shared decision making tools for communicating cardiovascular risk.
Huang RC, Song XT, Zhang DF, Xu JY, Boehmer KR, Leppin AA, Gionfriddo MR, Ting HH, Montori VM. Huang RC, et al. Among authors: montori vm. Chronic Dis Transl Med. 2019 Jun 17;5(2):105-112. doi: 10.1016/j.cdtm.2019.05.001. eCollection 2019 Jun. Chronic Dis Transl Med. 2019. PMID: 31367699 Free PMC article.
The frequency of changed responses was analyzed by using JMP 6.0 software. Data were statistically analyzed using Chi-square and Mann-Whitney U tests, as appropriate to the data type. ...RESULTS: Of the 200 young Chinese clinicians sampled, 59.0% indicated a preference for …
The frequency of changed responses was analyzed by using JMP 6.0 software. Data were statistically analyzed using Chi-square and Mann …
Incorporating a Genetic Risk Score Into Coronary Heart Disease Risk Estimates: Effect on Low-Density Lipoprotein Cholesterol Levels (the MI-GENES Clinical Trial).
Kullo IJ, Jouni H, Austin EE, Brown SA, Kruisselbrink TM, Isseh IN, Haddad RA, Marroush TS, Shameer K, Olson JE, Broeckel U, Green RC, Schaid DJ, Montori VM, Bailey KR. Kullo IJ, et al. Among authors: montori vm. Circulation. 2016 Mar 22;133(12):1181-8. doi: 10.1161/CIRCULATIONAHA.115.020109. Epub 2016 Feb 25. Circulation. 2016. PMID: 26915630 Free PMC article. Clinical Trial.
METHODS AND RESULTS: Participants (n=203, 45-65 years of age, at intermediate risk for CHD, and not on statins) were randomly assigned to receive their 10-year probability of CHD based either on a conventional risk score (CRS) or CRS + GRS ((+)GRS). ...Risk was disclosed b …
METHODS AND RESULTS: Participants (n=203, 45-65 years of age, at intermediate risk for CHD, and not on statins) were randomly assigne …
Should clinicians deliver decision aids? Further exploration of the statin choice randomized trial results.
Jones LA, Weymiller AJ, Shah N, Bryant SC, Christianson TJ, Guyatt GH, Gafni A, Smith SA, Montori VM. Jones LA, et al. Among authors: montori vm. Med Decis Making. 2009 Jul-Aug;29(4):468-74. doi: 10.1177/0272989X09333120. Epub 2009 Jul 15. Med Decis Making. 2009. PMID: 19605885 Clinical Trial.
BACKGROUND: Statin Choice is a decision aid about taking statins. The optimal mode of delivering Statin Choice (or any other decision aid) in clinical practice is unknown. ...We estimated between-group differences and their 95% confidence intervals (CI) for a …
BACKGROUND: Statin Choice is a decision aid about taking statins. The optimal mode of delivering Statin Choice (or any …
Effect of the statin choice encounter decision aid in Spanish patients with type 2 diabetes: A randomized trial.
Perestelo-Pérez L, Rivero-Santana A, Boronat M, Sánchez-Afonso JA, Pérez-Ramos J, Montori VM, Serrano-Aguilar P. Perestelo-Pérez L, et al. Among authors: montori vm. Patient Educ Couns. 2016 Feb;99(2):295-9. doi: 10.1016/j.pec.2015.08.032. Epub 2015 Sep 1. Patient Educ Couns. 2016. PMID: 26343571 Clinical Trial.
OBJECTIVE: Statin choice, an encounter decision aid (DA), was developed in the USA to facilitate shared decision making between patients and clinicians about the use of statins to reduce cardiovascular risk. ...CONCLUSION: The statin choice DA improved the qu …
OBJECTIVE: Statin choice, an encounter decision aid (DA), was developed in the USA to facilitate shared decision making between patie …
22 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page